St. Jude Medical, Inc. et al v. Access Closure, Inc.
ORDER - PERMANENT INJUNCTION. This permanent injunction shall run until the expiration of U.S. Patent No. 7,008,439, currently March 7, 2023. This Court retains jurisdiction to enforce any and all aspects of this Permanent Injunction. Signed by Honorable Harry F. Barnes on June 4, 2012. (cap)
IN THE UNITED STATES DISTRICT COURT
WESTERN DISTRICT OF ARKANSAS
ST. JUDE MEDICAL, INC. and
ST. JUDE MEDICAL PUERTO RICO, LLC
CASE NO. 08-CV-4101
ACCESS CLOSURE, INC.
Having reviewed and considered the jury's Verdict Form, the trial record, and the
Court’s own Findings Of Fact And Conclusions Of Law, as well as all pleadings, papers,
and other matters that have come before the Court in connection with this matter, IT IS
HEREBY ORDERED, ADJUDGED AND DECREED:
Defendant Access Closure, Inc. and its subsidiaries, successors, assigns, directors,
officers, agents, servants, employees, attorneys, representatives, and those persons in
active concert or participation with them who receive notice hereof, are hereby
immediately and permanently restrained and enjoined, pursuant to 35 U.S.C. § 283 and
Fed. R. Civ. P. 65(d), from making, using, offering for sale, selling, distributing or
otherwise providing in the United States, or importing into the United States, or causing
to be made, used, offered for sale, sold, distributed or otherwise provided in the United
States, or imported into the United States, the Infringing Products and all other products
that are no more than colorably different therefrom in the context of the claims of U.S.
Patent No. 7,008,439, either alone or in combination with any other product or as part of
any other product, and from inducing others to infringe, contributing to the infringement
of, or otherwise infringing U.S. Patent No. 7,008,439.
As used herein, the “Infringing Products” shall mean Defendant Access Closure,
Inc.'s Mynx vascular closure devices, including without limitation: MX5000, MX6700,
MX6750, MX5001, MX6701, MX6720, MX6721, Mynx 1.5, Mynx Cadence, and Mynx
Defendant Access Closure Inc. shall forthwith provide written notice of this
judgment, and the injunction ordered herein, to: its directors, officers, agents, servants,
employees, attorneys, representatives, and subsidiaries, and those persons in active
concert or participation with them, including any and all replicators, manufacturers,
distributors, retailers, customers and service providers who have been involved in the
making, using, selling, offering for sale, distributing, or importing of any Infringing
Products; and to all other persons or entities involved in any way with the making, using,
selling, offering for sale, distributing or importing of any Infringing Products. Defendant
Access Closure Inc. shall take whatever means are necessary or appropriate to ensure that
this order is properly complied with.
This permanent injunction shall run until the expiration of U.S. Patent No.
7,008,439, currently March 7, 2023. This Court retains jurisdiction to enforce any and all
aspects of this Permanent Injunction.
IT IS SO ORDERED this 4th day of June, 2012.
/s/ Harry F. Barnes
Hon. Harry F. Barnes
U.S. District Judge
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?